about
Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteinsSequence determinants of protein aggregation: tools to increase protein solubility.L-arginine hydrochloride increases the solubility of folded and unfolded recombinant plasminogen activator rPA.Ionic liquids as refolding additives: N'-alkyl and N'-(omega-hydroxyalkyl) N-methylimidazolium chlorides.L-Arginine increases the solubility of unfolded species of hen egg white lysozyme.Refolding and purification of recombinant L-asparaginase from inclusion bodies of E. coli into active tetrameric protein.Soluble prokaryotic overexpression and purification of bioactive human granulocyte colony-stimulating factor by maltose binding protein and protein disulfide isomerase.Novel approach of high cell density recombinant bioprocess development: optimisation and scale-up from microliter to pilot scales while maintaining the fed-batch cultivation mode of E. coli cultures.Maltose-binding protein enhances secretion of recombinant human granzyme B accompanied by in vivo processing of a precursor MBP fusion protein.Reducing conditions are the key for efficient production of active ribonuclease inhibitor in Escherichia coli.In situ visualization of newly synthesized proteins in environmental microbes using amino acid tagging and click chemistry.Protein solubility and differential proteomic profiling of recombinant Escherichia coli overexpressing double-tagged fusion proteins.Kinetics of inclusion body formation and its correlation with the characteristics of protein aggregates in Escherichia coli.Complete solubilization and purification of recombinant human growth hormone produced in Escherichia coli.Soluble expression of human leukemia inhibitory factor with protein disulfide isomerase in Escherichia coli and its simple purification.Prokaryotic soluble overexpression and purification of bioactive human growth hormone by fusion to thioredoxin, maltose binding protein, and protein disulfide isomerase.Expression and in vitro functional analyses of recombinant Gam1 proteinProkaryotic Soluble Overexpression and Purification of Human VEGF165 by Fusion to a Maltose Binding Protein TagEnzyme clustering accelerates processing of intermediates through metabolic channelingToxins from cone snails: properties, applications and biotechnological production.Chaperone-fusion expression plasmid vectors for improved solubility of recombinant proteins in Escherichia coli.A HUPO test sample study reveals common problems in mass spectrometry-based proteomics.A Spatial Control for Correct Timing of Gene Expression during the Escherichia coli Cell Cycle.A serendipitous survey of prediction algorithms for amyloidogenicity.Cancer wars: significance of protein unfolding in cancer and its inhibition with natural amphiphilic substances.Critical Factors Affecting the Success of Cloning, Expression, and Mass Production of Enzymes by Recombinant E. coli.Sophisticated Cloning, Fermentation, and Purification Technologies for an Enhanced Therapeutic Protein Production: A Review.A novel method to recover inclusion body protein from recombinant E. coli fed-batch processes based on phage ΦX174-derived lysis protein E.Production strategies for active heme-containing peroxidases from E. coli inclusion bodies - a review.Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during high-level SOD protein production.Optimization of expression and purification of HSPA6 protein from Camelus dromedarius in E. coli.Variability in subpopulation formation propagates into biocatalytic variability of engineered Pseudomonas putida strains.Rare codon content affects the solubility of recombinant proteins in a codon bias-adjusted Escherichia coli strain.Dynamic polar sequestration of excess MurG may regulate enzymatic function.Exchange of single amino acids at different positions of a recombinant protein affects metabolic burden in Escherichia coli.Prokaryotic soluble expression and purification of bioactive human fibroblast growth factor 21 using maltose-binding protein.
P2860
Q24792799-0A2AE12E-26C0-4F52-ABB0-50B2BF299DABQ24795353-5750B33B-5B84-4CA9-B6C8-1BF32FA73B10Q30318611-E90D7F8C-9A8E-412B-9730-1DB88944D529Q30320150-DA9D3190-F865-428F-944C-12340BD8755EQ30320276-FAE106FB-E811-483D-9DFC-76EDB0B09744Q30367759-2253BEE2-EBF2-4D6D-804D-3438AF3BA2B4Q31152401-E6232449-8685-4B9B-B40B-715A1DF072F5Q33582812-C93AEDA2-A924-4FDE-8E94-1A776E6599A0Q33784763-8A1CD7C6-D61F-42CE-A68D-B7F7341ED083Q33893399-2350988D-42B1-49BD-89A1-68100C327462Q34006258-B8C9170B-1988-4073-8CB9-1A76CA88370DQ34133521-FB9887AD-E10C-4AF7-8694-21D733EC0771Q34221832-C82EAA36-8C06-4101-A38C-DB8DED853E26Q34586736-C34E29BE-ECAD-4F8E-B519-4B562D6FC3B7Q35073178-91B8F37B-8F23-41FB-8021-9145F6FDECFDQ35116160-B7B66E7E-2BEF-442C-B350-D9A6146B8C8DQ35449374-17D250A3-8E53-41BF-B358-6DE5B635E6FBQ36032180-F9675CF9-3A63-4CF4-8046-500EEDABACFFQ36338073-E9621D44-4B85-44F7-85F6-A56201ABA115Q37109986-DE5260D9-1DC1-4166-A4D4-C3AD082E07F5Q37196642-FE96A244-553B-4E60-BA55-D71E62C06018Q37447178-C6509B84-F2B0-4D8A-A6A7-C9176DE3D771Q37628243-21912AE9-72B4-4596-BBFC-0F4C4C17EBDEQ38124811-31BBAE4C-CC22-4DB1-AD10-702D3625F541Q38234996-90FA656D-7834-40B1-B2AD-FA242A8CE307Q38477094-50935337-7404-43B5-9014-7CCC4E4C137EQ38654852-12274136-00FD-4CC8-93C7-C7FA13A1678FQ38827509-EE8B0DB7-B76E-40FF-8DC7-DEC608B058EFQ39205901-BFE4B0B7-DBC6-48B3-B8D7-D77A1C96845EQ39403691-939B4F75-EB74-4E6A-889E-622A889B63E1Q39802001-564B1C8B-8152-4A50-B793-E5D10E12ABCCQ41548175-F9218B7C-91F1-4E75-8944-E6CE0790016BQ41824344-2784118E-F684-4885-B30D-171C551B60F6Q42428418-EAAADBC7-2DF5-4B2B-8F5E-4233683A4B2DQ43120768-E3A1DA10-D102-49D4-AE82-E42E81D69F06Q47151186-A54B82D5-43F6-4CF7-BE91-BE13571E6E15
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inclusion bodies: formation and utilisation.
@ast
Inclusion bodies: formation and utilisation.
@en
type
label
Inclusion bodies: formation and utilisation.
@ast
Inclusion bodies: formation and utilisation.
@en
prefLabel
Inclusion bodies: formation and utilisation.
@ast
Inclusion bodies: formation and utilisation.
@en
P356
P1476
Inclusion bodies: formation and utilisation
@en
P2093
Hauke Lilie
Peter Neubauer
P304
P356
10.1007/B93995
P577
2004-01-01T00:00:00Z